Montrose (MEG): Buy, Sell, or Hold Post Q2 Earnings?

August 13, 2025 at 00:10 AM EDT

MEG Cover Image

The past six months have been a windfall for Montrose’s shareholders. The company’s stock price has jumped 49.9%, hitting $27.35 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Is now still a good time to buy MEG? Or is this a case of a company fueled by heightened investor enthusiasm? Find out in our full research report, it’s free.

Why Does MEG Stock Spark Debate?

Founded to protect a tree-lined two-lane road, Montrose (NYSE: MEG) provides air quality monitoring, environmental laboratory testing, compliance, and environmental consulting services.

Two Positive Attributes:

1. Skyrocketing Revenue Shows Strong Momentum

A company’s long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Thankfully, Montrose’s 24.5% annualized revenue growth over the last five years was incredible. Its growth surpassed the average industrials company and shows its offerings resonate with customers. Montrose Quarterly Revenue

2. Increasing Free Cash Flow Margin Juices Financials

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

As you can see below, Montrose’s margin expanded by 12.3 percentage points over the last five years. The company’s improvement shows it’s heading in the right direction, and we can see it became a less capital-intensive business because its free cash flow profitability rose more than its operating profitability. Montrose’s free cash flow margin for the trailing 12 months was 8%.

Montrose Trailing 12-Month Free Cash Flow Margin

One Reason to be Careful:

Slow Organic Growth Suggests Waning Demand In Core Business

We can better understand Waste Management companies by analyzing their organic revenue. This metric gives visibility into Montrose’s core business because it excludes one-time events such as mergers, acquisitions, and divestitures along with foreign currency fluctuations - non-fundamental factors that can manipulate the income statement.

Over the last two years, Montrose’s organic revenue averaged 4.5% year-on-year growth. This performance was underwhelming and suggests it may need to improve its products, pricing, or go-to-market strategy, which can add an extra layer of complexity to its operations. Montrose Organic Revenue Growth

Final Judgment

Montrose’s merits more than compensate for its flaws, and after the recent surge, the stock trades at 19.7× forward EV-to-EBITDA (or $27.35 per share). Is now a good time to buy despite the apparent froth? See for yourself in our comprehensive research report, it’s free.

Stocks We Like Even More Than Montrose

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

About Us

Additional Information

Website & Technical Help